InotivNOTV
Market Cap: $34.8M
About: Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Employees: 2,055
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
45% more call options, than puts
Call options by funds: $126K | Put options by funds: $87K
9.65% less ownership
Funds ownership: 25.61% [Q1] → 15.97% (-9.65%) [Q2]
32% less funds holding
Funds holding: 82 [Q1] → 56 (-26) [Q2]
48% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 25
79% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 33
90% less capital invested
Capital invested by funds: $71.9M [Q1] → $6.88M (-$65.1M) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for NOTV.